M42 introduced a new artificial intelligence tool for prostate cancer diagnostics today. The National Reference Laboratory partnered with digital pathology company Qritive for this launch.
Highlighting Suspicious Tissue
The smart system analyzes digital pathology slides and highlights suspicious tissue areas. Pathologists will use these structured insights to detect cancer much faster. Prostate cancer remains a growing health concern across the Middle East today.
Supporting Clinical Decisions
Doctors at Cleveland Clinic Abu Dhabi will integrate this technology into their daily workflows. The platform supports clinical decisions but leaves final diagnoses to medical professionals. This innovative initiative supports better patient outcomes across the Emirates.
Check out the newest medical tech breakthroughs and healthcare updates at The WAU.
Share This Post
